{
  "resourceType" : "SubstanceDefinition",
  "id" : "substance-adalimumab",
  "meta" : {
    "profile" : ["http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: SubstanceDefinition</b><a name=\"substance-adalimumab\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource SubstanceDefinition &quot;substance-adalimumab&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-SubstanceDefinition-uv-epi.html\">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: id:\u00a0FYS6T7F842\u00a0(use:\u00a0OFFICIAL)</p><p><b>version</b>: 1</p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>manufacturer</b>: <a href=\"Organization-mah-fda7514c0dcb7b5f0176cb5af274235f.html\">Organization/mah-fda7514c0dcb7b5f0176cb5af274235f</a> &quot;AbbVie Deutschland GmbH Co. KG&quot;</p><h3>Structures</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>MolecularFormula</b></td></tr><tr><td style=\"display: none\">*</td><td>C6448H10026O2016N1732S42</td></tr></table></div>"
  },
  "identifier" : [{
    "use" : "official",
    "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
    "value" : "FYS6T7F842"
  }],
  "version" : "1",
  "status" : {
    "coding" : [{
      "system" : "http://hl7.org/fhir/publication-status",
      "code" : "active"
    }]
  },
  "manufacturer" : [{
    "reference" : "Organization/mah-fda7514c0dcb7b5f0176cb5af274235f"
  }],
  "structure" : {
    "molecularFormula" : "C6448H10026O2016N1732S42"
  }
}